BrightSpring Health Services/$BTSG
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About BrightSpring Health Services
BrightSpring Health Services Inc is a home and community-based healthcare services platform, focused on delivering complementary pharmacy and provider services to complex patients. Its platform delivers clinical services and pharmacy solutions across Medicare, Medicaid, and commercially insured populations. Its segments include Pharmacy Solutions, Provider Services, and others. It generates the majority of its revenue from the Pharmacy Solutions segment.
Ticker
$BTSG
Sector
Primary listing
Employees
37,000
Headquarters
Website
BTSG Metrics
BasicAdvanced
$7B
55.60
$0.60
-
-
Price and volume
Market cap
$7B
52-week high
$35.01
52-week low
$15.26
Average daily volume
4.6M
Financial strength
Current ratio
1.794
Quick ratio
0.8
Long term debt to equity
143.025
Total debt to equity
148.231
Interest coverage (TTM)
2.34%
Profitability
EBITDA (TTM)
650.632
Gross margin (TTM)
13.28%
Net profit margin (TTM)
0.97%
Operating margin (TTM)
3.54%
Effective tax rate (TTM)
21.96%
Revenue per employee (TTM)
$360,000
Management effectiveness
Return on assets (TTM)
4.97%
Return on equity (TTM)
6.28%
Valuation
Price to earnings (TTM)
55.596
Price to revenue (TTM)
0.509
Price to book
3.35
Price to tangible book (TTM)
-6.5
Price to free cash flow (TTM)
24.518
Free cash flow yield (TTM)
4.08%
Free cash flow per share (TTM)
1.369
Growth
Revenue change (TTM)
37.13%
Earnings per share change (TTM)
-356.37%
3-year revenue growth (CAGR)
20.77%
3-year earnings per share growth (CAGR)
62.31%
What the Analysts think about BTSG
Analyst ratings (Buy, Hold, Sell) for BrightSpring Health Services stock.
Bulls say / Bears say
Strategic divestiture of the Community Living business to Sevita for $835 million, yielding approximately $715 million in after-tax proceeds, will accelerate deleveraging and allow BrightSpring to sharpen focus on its higher-margin pharmacy segment. (Investors.com)
Robust Q2 2025 performance with revenue rising 29.1% to $3.15 billion and adjusted EPS surging to $0.22 from $0.06 in Q2 2024, significantly outpacing analyst estimates and showcasing strong top-line and earnings momentum. (Nasdaq)
Raised full-year 2025 guidance to $12.2–$12.6 billion in revenue (21.1%–25.1% growth) and $590–$605 million in adjusted EBITDA (28.2%–31.5% growth), reflecting confidence in underlying business trends after excluding the divested Community Living unit. (Nasdaq)
Elevated leverage with net debt of approximately $2.5 billion and a leverage ratio of 3.6 times as of June 30, 2025 may constrain the company’s financial flexibility and increase vulnerability to interest rate hikes. (Investing.com)
Flat GAAP net income of $8.5 million in Q2 2025, despite 29.1% revenue growth and 28.8% EBITDA expansion, underscores the drag from $52.1 million in non-cash and one-off charges such as share-based compensation, transaction/integration, and restructuring costs. (Nasdaq)
Secondary offering of 14 million shares announced June 10, 2025 by affiliates of KKR and management introduces potential dilution risk for existing shareholders and may pressure the stock price. (Nasdaq)
Data summarised monthly by Lightyear AI. Last updated on 9 Nov 2025.
BTSG Financial Performance
Revenues and expenses
BTSG Earnings Performance
Company profitability
BTSG News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for BrightSpring Health Services stock?
BrightSpring Health Services (BTSG) has a market cap of $7B as of November 11, 2025.
What is the P/E ratio for BrightSpring Health Services stock?
The price to earnings (P/E) ratio for BrightSpring Health Services (BTSG) stock is 55.6 as of November 11, 2025.
Does BrightSpring Health Services stock pay dividends?
No, BrightSpring Health Services (BTSG) stock does not pay dividends to its shareholders as of November 11, 2025.
When is the next BrightSpring Health Services dividend payment date?
BrightSpring Health Services (BTSG) stock does not pay dividends to its shareholders.
What is the beta indicator for BrightSpring Health Services?
BrightSpring Health Services (BTSG) does not currently have a Beta indicator.